Skip to main content
. 2020 Dec 8;2:100064. doi: 10.1016/j.ijpx.2020.100064

Table 1.

Composition of samples used for the development and validation of the new analytical method.

Code RIV (% wt.)
ASDa (% wt.)
Crystalline Amorphous
F1b 0.25 0.75 99.00
F2 c 0.50 0.50 99.00
F3 c 2.25 0.75 97.00
F4 c 1.50 1.50 97.00
F5 c 1.25 3.75 95.00
F6 c 2.50 2.50 95.00
F7b 5.25 1.75 93.00
F8c 3.50 3.50 93.00
F9c 2.00 6.00 92.00
F10b 4.00 4.00 92.00
F11c 7.50 2.50 90.00
F12b 5.00 5.00 90.00
F13c 3.75 11.25 85.00
F14c 7.50 7.50 85.00
F15c 15.00 5.00 80.00
F16 c 10.00 10.00 80.00
F17c 7.50 22.50 70.00
F18c 15.00 15.00 70.00
F19b 30.00 10.00 60.00
F20c 20.00 20.00 60.00
F21b 12.50 37.50 50.00
F22c 25.00 25.00 50.00
F23c 45.00 15.00 40.00
F24b 30.00 30.00 40.00
F25c 17.50 52.50 30.00
F26c 35.00 35.00 30.00
F27c 60.00 20.00 20.00
F28c 40.00 40.00 20.00
F29b 22.50 67.50 10.00
F30c 45.00 45.00 10.00
a

ASD contained 20/80% wt. RIV/SOL

b

Test subset

c

Training subset